News

Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update

- Company to implement capital prioritization initiative, extending cash runway to 2H-2025 - - $127.5 million in cash, cash equivalents, restricted…

2 years ago

VitalHub Announces Q1 2023 Conference Call Date

TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce…

2 years ago

Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca

Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca MyMedi.ca to provide Medical Cannabis by Shoppers patients…

2 years ago

Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison

First-of-its-Kind Study in HIV Compares Ibalizumab Clinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA® CohortData Presented at ACTHIV™ Conference Highlight…

2 years ago

Arbutus Reports First Quarter 2023 Financial Results and Corporate Update

Additional AB-729 off-treatment data highlighted in an oral presentation at the Global Hepatitis Summit 2023 Dosed first subject in Phase…

2 years ago

Altimmune to Report First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023

GAITHERSBURG, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it…

2 years ago

Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET

REYKJAVIK, Iceland, May 03, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and…

2 years ago

Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced…

2 years ago

Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) ("Sirona") is…

2 years ago

Male Plus Makes It Easier to “Get in the Mood”

The Natural Libido Enhancer Delivers Impressive Results (Without the Awkward Side EffectFort Lauderdale, FL, May 03, 2023 (GLOBE NEWSWIRE) --…

2 years ago